URGENT: Hormone Therapy for Menopause: Critical Decisions Ahead - 6 Life-Changing Facts

Breaking News: FDA Removes Warning Labels from Hormone Therapy for Menopause The US Food and Drug Administration (FDA) has announced it will remove "black box" warning labels from estrogen-based hormone therapy, citing a shift in how estrogen is administered and new data that suggests the therapy is safer than previously thought. The move comes after 20 years of warning labels, which were added in response to the Women's Health Initiative study in the early 2000s. The study found that hormone therapy increased risks of heart attacks, strokes, blood clots, and breast cancer. However, FDA Commissioner Dr. Marty Makary says the warnings have made women scared to try the therapy and doctors reluctant to prescribe it. He argues that women should not suffer through menopause with hot flashes, night sweats, and poor sleep. The FDA's decision is a significant shift in how hormone therapy is viewed, and it could lead to more women seeking treatment for menopause symptoms. The agency's move is based on new data and a change in how estrogen is administered, but it's unclear how this will impact women's health in the long term. This is a developing story, and we will continue to provide updates as more information becomes available.